O
OLMA
Olema Pharmaceuticals, Inc.
10.90
-0.41-3.63%After Hours: 11.11 +0.21 +1.93%19:30 08/20 EDT
OPEN/PREV CLOSE11.10/11.31
TODAY RANGE10.67-11.12
VOL1.04M
MARKET CAP953.72M
52 WEEK RANGE5.34-36.26
AVG VOL (3M)1.44M
% TURNOVER1.19%
TURNOVER--
P/E (TTM)-5.1464
% RANGE3.89%
EPS(TTM)-2.1180
P/E(FORWARD)-4.4672
P/B2.214
BVPS4.923
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP931.16M
SHARES OUTSTANDING87.50M
NEXT EARNINGS11/09-11/13
FREE FLOAT85.43M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Dow Jones·08/13 15:38
Olema Pharmaceuticals Is Maintained at Overweight by JP Morgan
Dow Jones·08/13 15:38
Olema Pharmaceuticals Price Target Cut to $46.00/Share From $52.00 by JP Morgan
Seeking Alpha·08/13 13:25
Olema Oncology names Jason O’Byrne as CFO
TipRanks·08/13 11:57
J.P. Morgan Reaffirms Their Buy Rating on Olema Pharmaceuticals (OLMA)
Dow Jones·08/13 11:41
Olema Pharmaceuticals Appoints Jason O'Byrne as Finance Chief
TipRanks·08/13 11:34
Olema Pharmaceuticals Names New Chief Financial Officer
NASDAQ·08/13 11:17
Olema Appoints Jason O'Byrne As CFO
Dow Jones·08/13 11:00
Press Release: Olema Oncology Appoints Jason O'Byrne as Chief Financial Officer
Dow Jones·08/11 19:38
Olema Pharmaceuticals Is Maintained at Buy by Citigroup
Dow Jones·08/11 19:38
Olema Pharmaceuticals Price Target Cut to $59.00/Share From $62.00 by Citigroup
Benzinga·08/11 19:28
Citigroup Maintains Buy on Olema Pharmaceuticals, Lowers Price Target to $59
Benzinga·08/11 18:27
Olema Pharmaceuticals Stock Falls as Pivotal Breast Cancer Data Pushed Into 2027
Same Industry
Name/Symbol
Change%
Price